Developments in Cardiology from Day 2 of ACC.23

Developments in Cardiology from Day 2 of ACC.23
What did we learn from the second day of the American College of Cardiology's (ACC) 72nd Scientific Session & Expo? Here are some of the latest developments.
Heart Attack Deaths Drop Over Past Two Decades
A hopeful trend was highlighted in a study presented at this year’s American College of Cardiology conference, showing heart attack-related deaths in the U.S. dropped over the past 20 years. While there is a noticeable difference between the number of heart attack-related deaths for White and Black individuals, the study found the gap is shrinking.
Researchers explored this data in a session titled “Trends in Acute Myocardial Infarction Age-Adjusted Mortality Rates by Race in the USA: 1999-2020.” Based on data from the Centers for Disease Control and Prevention, researchers noted heart attack-related deaths fell by 4 percent a year from 1999-2020.
Heart attack-related deaths per 100,000 people were reported as follows:
- 87 overall in 1999
- 38 overall in 2020
- 104 Black individuals in 1999
- 46 Black individuals in 2020
According to the study, 17 more Black individuals per 100,000 died from heart attack-related causes than White individuals in 1999. This number remarkably shrank to only 8 more Black individuals per 100,000 in 2020.
Experts continue to try to pinpoint what caused the decline. Improved diagnostic tools, new treatment options, and a greater emphasis on healthy lifestyles certainly contributed to the 20-year decline. Notably, there were more heart attack-related deaths reported in 2020, but researchers believe this to be related to the COVID-19 pandemic. Despite that slight increase, the study clearly illustrated new prevention strategies and advanced treatment options are not only lowering the number of heart attack-related deaths but closing the gap in healthcare racial disparities.
Insights from the RAPID-HF Trial
Heart failure with preserved ejection fraction, or HFpEF, accounts for less than 50 percent of all heart failure patients. Because of this, there are only a few effective treatments for this condition.
In a session titled “Rate-Adaptive Atrial Pacing for Heart Failure with Preserved Ejection Fraction: The RAPID-HF Trial,” researchers predicted that the implementation of a rate-adaptive atrial pacemaker to augment exertional HR will improve exercise performance in patients with HFpEF and chronotropic incompetence.
The RAPID-HF trial was a single-center, double-blind, RCT that aimed to test the effects of rate-adaptive atrial pacing in patients with HFpEF. The primary endpoint was a VO2 at the anaerobic threshold. Some Of the secondary endpoints included peak VO2, ventilatory efficiency, patient-reported health status by the KCCQ-OSS, and safety.
To assess this, researchers evaluated patients on a pacing off/pacing on basis. They evaluated sinus rhythm and chronotropic incompetence.
Based on the results, the researchers were able to learn the following:
- With rate-adaptive atrial pacing, there were no beneficial improvements in heart rate during exercise performance or health status.
- The lack of a clear benefit may have to do with the decrease in stroke volume during exercise preventing gains in cardiac output
- Any adverse events were likely related to the implantation of the pacemaker and were infrequent
The trial’s key results don't support the use of rate-adaptive atrial pacing to treat patients with HFpEF and chronotropic incompetence.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Exploring the Use of AI to Detect HFpEF
Exploring the Use of AI to Detect HFpEF
Heart MattersExploring the Use of AI to Detect HFpEF
Closing Gaps in Care for Patients with T2D & CV Disease
Closing Gaps in Care for Patients with T2D & CV Disease
Diabetes DiscourseClosing Gaps in Care for Patients with T2D & CV Disease
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
ACC Action CenterThe Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
Highlights from Day 3 of ACC.23
Highlights from Day 3 of ACC.23
ACC Action CenterHighlights from Day 3 of ACC.23